Warburg-like effect is a hallmark of complex I assembly defects.
Citric Acid Cycle
Electron Transport Complex I
/ metabolism
Fibroblasts
/ cytology
Glycolysis
Humans
Metabolic Engineering
Mitochondria
/ metabolism
Mitochondrial Diseases
/ metabolism
NADH Dehydrogenase
/ antagonists & inhibitors
Principal Component Analysis
RNA Interference
RNA, Small Interfering
/ metabolism
Reactive Oxygen Species
/ metabolism
Complex I assembly
Complex I deficiency
Metabolic reprogramming
Mitochondrial metabolism
ROS production
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 09 2019
01 09 2019
Historique:
received:
18
12
2018
revised:
13
05
2019
accepted:
15
05
2019
pubmed:
24
5
2019
medline:
8
5
2020
entrez:
24
5
2019
Statut:
ppublish
Résumé
Due to its pivotal role in NADH oxidation and ATP synthesis, mitochondrial complex I (CI) emerged as a crucial regulator of cellular metabolism. A functional CI relies on the sequential assembly of nuclear- and mtDNA-encoded subunits; however, whether CI assembly status is involved in the metabolic adaptations in CI deficiency still remains largely unknown. Here, we investigated the relationship between CI functions, its structure and the cellular metabolism in 29 patient fibroblasts representative of most CI mitochondrial diseases. Our results show that, contrary to the generally accepted view, a complex I deficiency does not necessarily lead to a glycolytic switch, i.e. the so-called Warburg effect, but that this particular metabolic adaptation is a feature of CI assembly defect. By contrast, a CI functional defect without disassembly induces a higher catabolism to sustain the oxidative metabolism. Mechanistically, we demonstrate that reactive oxygen species overproduction by CI assembly intermediates and subsequent AMPK-dependent Pyruvate Dehydrogenase inactivation are key players of this metabolic reprogramming. Thus, this study provides a two-way-model of metabolic responses to CI deficiencies that are central not only in defining therapeutic strategies for mitochondrial diseases, but also in all pathophysiological conditions involving a CI deficiency.
Identifiants
pubmed: 31121247
pii: S0925-4439(19)30171-1
doi: 10.1016/j.bbadis.2019.05.011
pii:
doi:
Substances chimiques
RNA, Small Interfering
0
Reactive Oxygen Species
0
NADH Dehydrogenase
EC 1.6.99.3
Electron Transport Complex I
EC 7.1.1.2
NDUFAF1 protein, human
EC 7.1.1.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2475-2489Informations de copyright
Copyright © 2019. Published by Elsevier B.V.